Dalas Biotech Limited, a active public limited company, was established on 18 July 1989 in Bhiwadi, Rajasthan, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232RJ1989PLC005056. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹4.48 Cr.
Formerly known as Aimil Medicaments India Pvt Ltd, Sudman Laboratories Limited. It upholds a compliant status. Employing 297 professional, Its leadership includes Mukesh Kumar (Director), Sangita Rajani (Whole-Time Director), Shambhu Yadav (Director). Past directors included Atul Rajani, Anil Kumar Rajani, Bodh Raj Sikri. It holds ₹28.95 Cr open charges and ₹142.12 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-292, Riico Industrial Area,, Bhiwadi, Rajasthan, 301019.
U24232RJ1989PLC005056
005056
18 July 1989
₹10.00 Cr
₹4.48 Cr
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Dalas Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Kumar | Director | 15 Mar 2021 | Current |
| Sangita Rajani | Whole-Time Director | 25 Mar 2015 | Current |
| Shambhu Yadav | Director | 06 Jan 2023 | Current |
| Deepika Rajani | Director | 24 Sep 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Sep 2017 | Past |
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Director | 23 Nov 2017 | Past |
| Pramod Abcsdd | Director | 15 Aug 2018 | Past |
| Pramod Abcsdd | Director | 01 Oct 2016 | Past |
| Pramod Abcsdd | Director | 30 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dalas Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.68% increase. The company also saw a substantial improvement in profitability, with a 36.47% increase in profit. The company's net worth moved up by a moderate rise of 0.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dalas Biotech had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹289,508,998.00
₹1,421,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Oct 2025 | Others | ₹20.00 Cr | Open |
| 19 Mar 2025 | Others | ₹4.70 Cr | Open |
| 27 Jan 2025 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 10 Nov 2023 | Hdfc Bank Limited | ₹1.25 Cr | Open |
| 27 Jun 2023 | Hdfc Bank Limited | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Dalas Biotech has a workforce of 297 employees as of Aug 01, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dalas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dalas Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101174292 was registered on 03 Oct 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 4.70 Cr with Charge ID 101063130 was registered on 19 Mar 2025. was recorded as a recent event.
The activity A charge registered on 26 Oct 2021 via Charge ID 100496999 with Others was fully satisfied on 04 Mar 2025. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 1.50 Cr with Charge ID 101040132 was registered on 27 Jan 2025. was recorded as a recent event.
Progress on Dalas Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Dalas Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was documented.
The CIN of Dalas Biotech Limited is U24232RJ1989PLC005056.
Dalas Biotech Limited is headquartered at E-292, Riico Industrial Area,, Bhiwadi, Rajasthan, 301019.
Dalas Biotech Limited was incorporated on 18 July 1989.
The current directors of Dalas Biotech Limited are
The primary industry of Dalas Biotech Limited is Manufacturing.
Dalas Biotech Limited is unlisted.
The authorized capital of Dalas Biotech Limited is ₹10.00 Cr, and the paid-up capital is ₹4.48 Cr.
The compliance status of Dalas Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX